Literature DB >> 20530667

High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.

Francesco Esposito1, Mara Tornincasa, Paolo Chieffi, Ivana De Martino, Giovanna Maria Pierantoni, Alfredo Fusco.   

Abstract

We have previously described a mechanism through which the high-mobility group A1 (HMGA1) proteins inhibit p53-mediated apoptosis by delocalizing the p53 proapoptotic activator homeodomain-interacting protein kinase 2 from the nucleus to the cytoplasm. By this mechanism, HMGA1 modulates the transcription of p53 target genes such as Mdm2, p21(waf1), and Bax, inhibiting apoptosis. Here, we report that HMGA1 antagonizes the p53-mediated transcriptional repression of another apoptosis-related gene, Bcl-2, suggesting a novel mechanism by which HMGA1 counteracts apoptosis. Moreover, HMGA1 overexpression promotes the reduction of Brn-3a binding to the Bcl-2 promoter, thereby blocking the Brn-3a corepressor function on Bcl-2 expression following p53 activation. Consistently, a significant direct correlation between HMGA1 and Bcl-2 overexpression has been observed in human breast carcinomas harboring wild-type p53. Therefore, this study suggests a novel mechanism, based on Bcl-2 induction, by which HMGA1 overexpression contributes to the escape from apoptosis leading to neoplastic transformation. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530667     DOI: 10.1158/0008-5472.CAN-09-4199

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Hmga1 null mouse embryonic fibroblasts display downregulation of spindle assembly checkpoint gene expression associated to nuclear and karyotypic abnormalities.

Authors:  Giovanna Maria Pierantoni; Andrea Conte; Cinzia Rinaldo; Mara Tornincasa; Raffaele Gerlini; Davide Valente; Antonella Izzo; Alfredo Fusco
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.

Authors:  Shaohui Yuan; Qi Pan; Chunjiang Fu; Zhenggang Bi
Journal:  Mol Cell Biochem       Date:  2011-05-15       Impact factor: 3.396

3.  CBX7 is a tumor suppressor in mice and humans.

Authors:  Floriana Forzati; Antonella Federico; Pierlorenzo Pallante; Adele Abbate; Francesco Esposito; Umberto Malapelle; Romina Sepe; Giuseppe Palma; Giancarlo Troncone; Marzia Scarfò; Claudio Arra; Monica Fedele; Alfredo Fusco
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 4.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

5.  Potential Role for a β-Catenin Coactivator (High-Mobility Group AT-Hook 1 Protein) during the Latency-Reactivation Cycle of Bovine Herpesvirus 1.

Authors:  Liqian Zhu; Aspen Workman; Clinton Jones
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

Review 6.  Critical role of HMGA proteins in cancer cell chemoresistance.

Authors:  Daniela D'Angelo; Paula Mussnich; Claudio Arra; Sabrina Battista; Alfredo Fusco
Journal:  J Mol Med (Berl)       Date:  2017-03-14       Impact factor: 4.599

Review 7.  High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.

Authors:  Lu Wang; Ji Zhang; Min Xia; Chang Liu; Xuyu Zu; Jing Zhong
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

8.  Association of SIRT1 and HMGA1 expression in non-small cell lung cancer.

Authors:  Shuang-Yan Lin; Fang Peng
Journal:  Oncol Lett       Date:  2015-11-13       Impact factor: 2.967

9.  High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria.

Authors:  F Esposito; M Tornincasa; A Federico; G Chiappetta; G M Pierantoni; A Fusco
Journal:  Cell Death Dis       Date:  2012-08-30       Impact factor: 8.469

10.  HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.

Authors:  Lavinia Nardinocchi; Rosa Puca; Gabriella D'Orazi
Journal:  Aging (Albany NY)       Date:  2011-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.